In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
However, like all research peptides, it must be used only in non-human laboratory settings , and should never be promoted or interpreted as a therapeutic product
And, what happens if you take too much
Are there B-12 Injection side effects
Also referenced as BPC-157 , it is frequently used in laboratory models examining repair signaling and angiogenesis-related activity and cellular response mechanisms
The products are typically sold as freeze-dried powders that buyers reconstitute into injectable solutions